Xepa – Soul Pattinson | Leading Manufacturer of Off-Patent Pharmaceuticals

Provisionally Registered Pharmacist (PRP) Program

What is Provisionally Registered Pharmacist (PRP) Program?

  • An opportunity for bright pharmacy graduates to intern at a leading pharmaceutical company
  • 2 years Internship Program at Xepa-Soul Pattinson (Malaysia)

 

 

 

program outline

What is in the Program?

  • Bridge the gap between theory and practice
  • Comply with competency standard set by the Pharmacy Board
  • Career Opportunity in Xepa’s winning team


Program Outline

  • Facilitated by a Master Preceptor at Xepa-Soul Pattinson (Malaysia)
  • Compulsory modules & guidelines set by Ministry of Health (MOH)
  • Financial Literacy
  • Industrial and Quality Management


Program
Highlights

  • 12 months as PRP followed by 12 months of structured training under guidance of mentor
  • Problem-based learning, projects and assignments
  • Tutorship and mentorship in various business aspects
  • Periodic reviews and appraisals

Work Placement

  • Factory production & packaging
  • Laboratory
  • Quality Assurance (QA )
  • Innovation & Development (I&D) and Regulatory Affairs (RA)
  • Marketing
  • Retail Exposure


Selecting The Best

  • Upper quintile of graduating class
  • English proficiency: spoken and written
  • Aptitude test & psychometric assessment


Career Paths in Xepa-Soul Pattinson (Malaysia) / Apex Healthcare Berhad
(AHB)

  • Production and Quality Management
  • Innovation & Development
  • Corporate & Regulatory Affairs
  • Sales & Marketing – domestic, regional & international
  • Operations & Distribution


Special Modules Offered

  • Industrial
  • Good Manufacturing Practice
  • Quality Systems and Tools
  • Management
  • Project Management Tools
  • Teamwork & Communication


Duration of Contract

  • 24 months contractual employment. Opportunities for full-time employment.


Interested to apply?

  • Please write in to jobs@xepasp.com with detailed resume, certificates attachments and a photograph.